(19)
(11) EP 1 353 657 A1

(12)

(43) Date of publication:
22.10.2003 Bulletin 2003/43

(21) Application number: 02732099.3

(22) Date of filing: 10.01.2002
(51) International Patent Classification (IPC)7A61K 31/00
(86) International application number:
PCT/IB0200/042
(87) International publication number:
WO 0205/6871 (25.07.2002 Gazette 2002/30)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.01.2001 GB 0101223

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)

    GB 
  • Pfizer Global Research and Development
    Kent CT13 9NJ (GB)

    AT BE CH CY DE DK ES FI FR GR IE IT LU MC NL PT SE TR LI 

(72) Inventors:
  • JENKINSON, Stephen,Pfizer Global Res. and Dev.
    Kent CT13 9NJ (GB)
  • O'REILLY, Mark Anthony,Pfizer Global Res. and Dev
    Kent CT13 9NJ (GB)
  • TREVETHICK, Michael A.,Pfizer Global Res. and Dev
    Kent CT139NJ (GB)

(74) Representative: Hirsch, Denise Marie 
Pfizer Global Research & Development3-9, rue de la Loge / B.P. 100
94265 Fresnes Cedex
94265 Fresnes Cedex (FR)

   


(54) HISTAMINE H4 RECEPTOR ANTAGONISTS